NNovo Nordisk Read More Novo Nordisk Weaves a Safety Net: Hemophilia Drug Advances as GLP-1 Revenue Faces Halving in 20272026-07-14 Novo Nordisk is trying to rebuild its story on two fronts at once. The Danish drugmaker’s stock has…